demonstrated that exenatide was effective in treating obese patients with type 2 diabetes, resulting in weight loss and reductions in glycosylated hemoglobin (HbAlc), systolic blood pressure, triglycerides, and high-sensitivity C-reactive protein (CRP) (39). This evidence concerns the gene CRP and type 2 diabetes mellitus.